Production of Molybdenum-99 by Heterogeneous and Homogeneous Uranium Fueled Reactors

Abstract

The use of radioisotopes for various procedures in the health care industry has become one of the most important practices in medicine. At the forefront of the medical isotope list is molybdenum-99 and its daughter isotope technetium-99m, which encompass over 80% of radiopharmaceutical procedures [1]. Fission of uranium-235 to produce molybdenum-99 is the most widely used method for producing this radioisotope. The heterogeneous reactor and the aqueous homogeneous reactor are looked at here with emphasis on the use of low enriched uranium as the fuel source. Methods of technetium-99m generation and its medical use are also reviewed.